➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Boehringer Ingelheim
McKesson
Merck
Medtronic

Last Updated: June 21, 2021

DrugPatentWatch Database Preview

NEULASTA Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for NEULASTA

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Children's Oncology GroupPhase 2
Ottawa Hospital Research InstitutePhase 4
Qilu Pharmaceutical Co., Ltd.Phase 1

See all NEULASTA clinical trials

Company Disclosures: US Patents for NEULASTA

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31   Get Started Free Amgen Inc. (Thousand Oaks, CA) 2013-12-03 RX Orphan company
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31   Get Started Free Amgen Inc. (Thousand Oaks, CA) 2013-12-10 RX Orphan company
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31   Get Started Free Amgen Inc. (Thousand Oaks, CA) 2039-02-26 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for NEULASTA

These patents were identified by searching patent claims

Supplementary Protection Certificates for NEULASTA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
SZ 5/2003 Austria   Get Started Free PRODUCT NAME: PEGFILGRASTIM
C300106 Netherlands   Get Started Free PRODUCT NAME: PEGFILGRASTIM; NAT. REGISTRATION NO/DATE: EU/1/02/228/001 20020822; FIRST REGISTRATION: EU/1/02/228/001 20020822
2002C/040 Belgium   Get Started Free PRODUCT NAME: PEGFILGRASTIM; AUTHORISATION NUMBER AND DATE: EU/1/02/227/001 20020823
300106 Netherlands   Get Started Free PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/228/001 20020822
10299044 Germany   Get Started Free PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/227/001 20020822
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Johnson and Johnson
Moodys
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.